Why Biofrontera Inc (NASDAQ: BFRI) Stock Shouldn’t Be Ignored In 2024

In the last trading session, 1.38 million shares of the Biofrontera Inc (NASDAQ:BFRI) were traded, and its beta was 0.37. Most recently the company’s share price was $1.19, and it changed around $0.04 or 3.48% from the last close, which brings the market valuation of the company to $9.22M. BFRI currently trades at a discount to its 52-week high of $4.00, offering almost -236.13% off that amount. The share price’s 52-week low was $0.61, which indicates that the current value has risen by an impressive 48.74% since then. We note from Biofrontera Inc’s average daily trading volume that its 10-day average is 1.0 million shares, with the 3-month average coming to 2.84 million.

Biofrontera Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended BFRI as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Biofrontera Inc is expected to report earnings per share of -0.07 for the current quarter.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Biofrontera Inc (NASDAQ:BFRI) trade information

Instantly BFRI has showed a green trend with a performance of 3.48% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.2450 on recent trading dayincreased the stock’s daily price by 4.42%. The company’s shares are currently down -57.04% year-to-date, but still up 27.12% over the last five days. On the other hand, Biofrontera Inc (NASDAQ:BFRI) is 39.00% up in the 30-day period. We can see from the shorts that 0.46 million shares have been sold at a short interest cover period of 0.08 day(s).

Biofrontera Inc (BFRI) estimates and forecasts

Biofrontera Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 26.58 percent over the past six months and at a 81.39% annual growth rate that is well above the industry average of 17.10%. The year-over-year growth rate is expected to be 15.38%, up from the previous year.

Consensus estimates provided by 2 financial analysts predict the company will bring in an average of 14.53M in revenue for the current quarter. 2 analysts expect Biofrontera Inc to make 11.5M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 10.6M and 7.91M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 37.13%. Forecasts for the next quarter put sales growth at 45.35%.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 7.90%.

BFRI Dividends

Biofrontera Inc’s next quarterly earnings report is expected to be released in January.

Biofrontera Inc (NASDAQ:BFRI)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 32.06% of Biofrontera Inc shares, and 20.68% of them are in the hands of institutional investors. The stock currently has a share float of 30.44%.